Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Cardiogenic shock after acute myocardial infarction: a review
Importance Cardiogenic shock affects between 40 000 and 50 000 people in the US per
year and is the leading cause of in-hospital mortality following acute myocardial infarction …
year and is the leading cause of in-hospital mortality following acute myocardial infarction …
Epidemiology, pathophysiology and contemporary management of cardiogenic shock–a position statement from the Heart Failure Association of the European Society …
Cardiogenic shock (CS) is a complex multifactorial clinical syndrome with extremely high
mortality, develo** as a continuum, and progressing from the initial insult (underlying …
mortality, develo** as a continuum, and progressing from the initial insult (underlying …
Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials
U Zeymer, A Freund, M Hochadel, P Ostadal… - The Lancet, 2023 - thelancet.com
Background Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly
used in patients with cardiogenic shock despite the lack of evidence from adequately …
used in patients with cardiogenic shock despite the lack of evidence from adequately …
Management of cardiogenic shock complicating myocardial infarction: an update 2019
Cardiogenic shock (CS) remains the most common cause of death in patients admitted with
acute myocardial infarction (AMI) and mortality remained nearly unchanged in the range of …
acute myocardial infarction (AMI) and mortality remained nearly unchanged in the range of …
JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome
Acute coronary syndromes (ACS) are a comprehensive disease concept characterized by
acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …
acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …
Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomized IABP-SHOCK II trial
Background: The role of intraaortic balloon counterpulsation (IABP) in cardiogenic shock is
still a subject of intense debate despite the neutral results of the IABP-SHOCK II trial …
still a subject of intense debate despite the neutral results of the IABP-SHOCK II trial …
Fifteen‐year trends in incidence of cardiogenic shock hospitalization and in‐hospital mortality in the United States
Background There is a lack of contemporary data on cardiogenic shock (CS) in‐hospital
mortality trends. Methods and Results Patients with CS admitted January 1, 2004 to …
mortality trends. Methods and Results Patients with CS admitted January 1, 2004 to …
Temporary circulatory support for cardiogenic shock
Cardiogenic shock can occur due to acute ischaemic or non-ischaemic cardiac events, or
from progression of long-standing underlying heart disease. When addressing the cause of …
from progression of long-standing underlying heart disease. When addressing the cause of …
The evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support
Background: Impella was approved for mechanical circulatory support (MCS) in 2008, but
large-scale, real-world data on its use are lacking. Our objective was to describe trends and …
large-scale, real-world data on its use are lacking. Our objective was to describe trends and …
Timing of active left ventricular unloading in patients on venoarterial extracorporeal membrane oxygenation therapy
Background It is currently unclear if active left ventricular (LV) unloading should be used as
a primary treatment strategy or as a bailout in patients with cardiogenic shock (CS) treated …
a primary treatment strategy or as a bailout in patients with cardiogenic shock (CS) treated …